A Bioequivalence Study of the Lu AA21004 20 mg and 2×10 mg Tablets
NCT03437564
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
28
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Adult Participants
Interventions
DRUG:
Vortioxetine
Sponsor
Takeda